Growth Metrics

Opus Genetics (IRD) Short-term Investments (2010 - 2025)

Opus Genetics (IRD) reported Short-term Investments of $1000.0 for Q1 2025, down 80.0% year-over-year from $5000.0 in Q1 2024, and down 50.0% on a QoQ basis from $2000.0 in Q4 2024.

Opus Genetics (IRD) has 15 years of Short-term Investments data on file, last reported at $1000.0 in Q1 2025.

  • Quarterly Short-term Investments fell 80.0% year-over-year to $1000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1000.0 (down 80.0% YoY) and the FY2024 annual result came in at $2000.0, down 86.67% from the prior year.
  • Short-term Investments fell to $1000.0 in Q1 2025 per IRD's latest filing, from $2000.0 in the prior quarter.
  • Across five years, Short-term Investments topped out at $383000.0 in Q3 2021 and bottomed at $1000.0 in Q1 2025.
  • The 5-year median for Short-term Investments is $22000.0 (2023), against an average of $73266.7.
  • Peak annual rise in Short-term Investments reached 69.39% in 2023, while the deepest fall reached 89.11% in 2023.
  • Tracing IRD's Short-term Investments over 5 years: stood at $219000.0 in 2021, then slumped by 77.63% to $49000.0 in 2022, then sank by 69.39% to $15000.0 in 2023, then tumbled by 86.67% to $2000.0 in 2024, then tumbled by 50.0% to $1000.0 in 2025.
  • Per Business Quant, the three latest IRD Short-term Investments figures stand at $1000.0 (Q1 2025), $2000.0 (Q4 2024), and $3000.0 (Q3 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Opus Genetics 357.99 Mn 298.03 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 1,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 3,000.00
Jun 30, 2024 5,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 15,000.00
Sep 30, 2023 11,000.00
Jun 30, 2023 22,000.00
Mar 31, 2023 22,000.00
Dec 31, 2022 49,000.00
Sep 30, 2022 101,000.00
Jun 30, 2022 126,000.00
Mar 31, 2022 135,000.00
Dec 31, 2021 219,000.00
Sep 30, 2021 383,000.00
Dec 31, 2019 3.00 Mn
Sep 30, 2019 5.98 Mn
Jun 30, 2019 8.95 Mn
Mar 31, 2019 11.89 Mn
Dec 31, 2018 5.98 Mn
Sep 30, 2018 7.97 Mn
Jun 30, 2018 11.65 Mn
Mar 31, 2018 14.88 Mn
Dec 31, 2017 17.93 Mn
Sep 30, 2017 14.98 Mn
Jun 30, 2017 17.99 Mn
Mar 31, 2017 8.02 Mn
Dec 31, 2016 8.74 Mn
Sep 30, 2016 13.42 Mn
Jun 30, 2016 11.52 Mn
Mar 31, 2016 14.01 Mn
Dec 31, 2015 13.24 Mn
Sep 30, 2015 9.01 Mn
Jun 30, 2015 16.01 Mn
Mar 31, 2015 18.66 Mn
Dec 31, 2014 22.87 Mn
Sep 30, 2014 20.61 Mn
Jun 30, 2014 100,000.00
Mar 31, 2014 100,000.00
Dec 31, 2013 100,000.00
Sep 30, 2013 100,000.00
Jun 30, 2013 100,000.00
Mar 31, 2013 100,000.00
Dec 31, 2012 100,000.00
Sep 30, 2012 100,000.00
Jun 30, 2012 100,000.00
Mar 31, 2012 1.95 Mn
Dec 31, 2011 1.95 Mn
Sep 30, 2011 1.95 Mn
Jun 30, 2011 1.95 Mn
Dec 31, 2010 2.45 Mn